Goldman Sachs’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $224M | Buy |
|
|||||
|
2025
Q2 | $214M | Buy |
|
|||||
|
2025
Q1 | $185M | Buy |
|
|||||
|
2024
Q4 | $162M | Sell |
|
|||||
|
2024
Q3 | $212M | Sell |
|
|||||
|
2024
Q2 | $370M | Buy |
|
|||||
|
2024
Q1 | $334M | Sell |
|
|||||
|
2023
Q4 | $268M | Buy |
|
|||||
|
2023
Q3 | $240M | Sell |
|
|||||
|
2023
Q2 | $445M | Sell |
|
|||||
|
2023
Q1 | $392M | Buy |
|
|||||
|
2022
Q4 | $256M | Buy |
|
|||||
|
2022
Q3 | $269M | Buy |
|
|||||
|
2022
Q2 | $286M | Buy |
|
|||||
|
2022
Q1 | $295M | Sell |
|
|||||
|
2021
Q4 | $364M | Buy |
|
|||||
|
2021
Q3 | $314M | Buy |
|
|||||
|
2021
Q2 | $246M | Sell |
|
|||||
|
2021
Q1 | $231M | Sell |
|
|||||
|
2020
Q4 | $274M | Sell |
|
|||||
|
2020
Q3 | $381M | Sell |
|
|||||
|
2020
Q2 | $385M | Sell |
|
|||||
|
2020
Q1 | $360M | Buy |
|
|||||
|
2019
Q4 | $421M | Buy |
|
|||||
|
2019
Q3 | $262M | Sell |
|
|||||
|
2019
Q2 | $269M | Buy |
|
|||||
|
2019
Q1 | $255M | Buy |
|
|||||
|
2018
Q4 | $184M | Sell |
|
|||||
|
2018
Q3 | $278M | Sell |
|
|||||
|
2018
Q2 | $269M | Sell |
|
|||||
|
2018
Q1 | $346M | Buy |
|
|||||
|
2017
Q4 | $264M | Buy |
|
|||||
|
2017
Q3 | $235M | Sell |
|
|||||
|
2017
Q2 | $314M | Buy |
|
|||||
|
2017
Q1 | $246M | Buy |
|
|||||
|
2016
Q4 | $216M | Buy |
|
|||||
|
2016
Q3 | $252M | Buy |
|
|||||
|
2016
Q2 | $121M | Sell |
|
|||||
|
2016
Q1 | $146M | Sell |
|
|||||
|
2015
Q4 | $157M | Buy |
|
|||||
|
2015
Q3 | $92.4M | Sell |
|
|||||
|
2015
Q2 | $106M | Buy |
|
|||||
|
2015
Q1 | $84M | Buy |
|
|||||
|
2014
Q4 | $45.3M | Buy |
|
|||||
|
2014
Q3 | $22.9M | Sell |
|
|||||
|
2014
Q2 | $20.5M | Sell |
|
|||||
|
2014
Q1 | $19.6M | Sell |
|
|||||
|
2013
Q4 | $20.5M | Sell |
|
|||||
|
2013
Q3 | $126M | Buy |
|
|||||
|
2013
Q2 | $43.1M | Buy |
|